Jazz Pharmaceuticals (JAZZ) Tax Provisions (2012 - 2026)
Jazz Pharmaceuticals' quarterly Tax Provisions came in at $6.1 million in Q1 2026, up 134.27% year-on-year from $2.6 million in Q1 2025, and up 22.0% quarter-over-quarter from $5.0 million in Q4 2025.
Jazz Pharmaceuticals has reported Tax Provisions for 15 years, with the latest figure at $6.1 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 134.27% year-over-year to $6.1 million; the trailing twelve-month figure through Mar 2026 stood at -$248.5 million (down 105.57% YoY), and the FY2025 full-year result was -$272.4 million, down 197.94% from the prior year.
- Tax Provisions for Q1 2026 stood at $6.1 million, up from $5.0 million in the prior quarter.
- The five-year high for Tax Provisions was $11.7 million in Q1 2024, with the low at -$242.4 million in Q3 2025.
- Average Tax Provisions over 5 years is -$37.4 million, with a median of -$17.8 million recorded in 2025.
- Year-over-year, Tax Provisions tumbled 3164.8% in 2023 and surged 176.35% in 2024.
- Tracing JAZZ's Tax Provisions over 5 years: stood at -$100.0 million in 2022, then soared by 66.9% to -$33.1 million in 2023, then sank by 74.9% to -$57.9 million in 2024, then surged by 108.63% to $5.0 million in 2025, then advanced by 22.0% to $6.1 million in 2026.
- The last three Tax Provisions figures came in at $6.1 million (Q1 2026), $5.0 million (Q4 2025), and -$242.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn | 6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.10 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | -242.42 Mn |
| Jun 30, 2025 | -17.20 Mn |
| Mar 31, 2025 | -17.80 Mn |
| Dec 31, 2024 | -57.91 Mn |
| Sep 30, 2024 | -14.53 Mn |
| Jun 30, 2024 | -30.65 Mn |
| Mar 31, 2024 | 11.70 Mn |
| Dec 31, 2023 | -33.11 Mn |
| Sep 30, 2023 | -47.20 Mn |
| Jun 30, 2023 | -24.30 Mn |
| Mar 31, 2023 | -15.32 Mn |
| Dec 31, 2022 | -100.04 Mn |
| Sep 30, 2022 | -43.00 Mn |
| Jun 30, 2022 | -16.11 Mn |
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | -12.48 Mn |
| Sep 30, 2021 | -18.06 Mn |
| Jun 30, 2021 | 228.60 Mn |
| Mar 31, 2021 | 18.00 Mn |
| Dec 31, 2020 | 10.77 Mn |
| Sep 30, 2020 | 19.28 Mn |
| Jun 30, 2020 | 54.80 Mn |
| Mar 31, 2020 | -51.30 Mn |
| Dec 31, 2019 | -34.52 Mn |
| Sep 30, 2019 | 10.90 Mn |
| Jun 30, 2019 | -78.65 Mn |
| Mar 31, 2019 | 29.10 Mn |
| Dec 31, 2018 | 5.14 Mn |
| Sep 30, 2018 | 19.30 Mn |
| Jun 30, 2018 | 36.52 Mn |
| Mar 31, 2018 | 19.15 Mn |
| Dec 31, 2017 | -113.65 Mn |
| Sep 30, 2017 | 1.24 Mn |
| Jun 30, 2017 | 35.52 Mn |
| Mar 31, 2017 | 29.16 Mn |
| Dec 31, 2016 | 34.35 Mn |
| Sep 30, 2016 | 26.44 Mn |
| Jun 30, 2016 | 42.11 Mn |
| Mar 31, 2016 | 32.34 Mn |
| Dec 31, 2015 | 13.75 Mn |
| Sep 30, 2015 | 29.95 Mn |
| Jun 30, 2015 | 30.65 Mn |
| Mar 31, 2015 | 32.06 Mn |
| Dec 31, 2014 | 33.63 Mn |
| Sep 30, 2014 | 24.22 Mn |
| Jun 30, 2014 | 19.35 Mn |
| Mar 31, 2014 | 17.03 Mn |
| Sep 30, 2013 | 18.34 Mn |
| Jun 30, 2013 | 23.61 Mn |
| Mar 31, 2013 | 17.63 Mn |
| Dec 31, 2012 | -108.76 Mn |
| Sep 30, 2012 | 12.86 Mn |
| Jun 30, 2012 | 6.59 Mn |
| Mar 31, 2012 | 5.52 Mn |